Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Sale

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
British Journal of Clinical Pharmacology|June 19, 2013
A genetic algorithm based global search strategy for population pharmacokinetic/pharmacodynamic model selectionMark Sale, Eric A Sherer
Clinical and Translational Science|February 6, 2025
AI In Action: Redefining Drug Discovery and DevelopmentAnshul Kanakia, Mark Sale, Liang Zhao, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2002
Pharmacokinetic modeling and simulations of interaction of amprenavir and ritonavirMark Sale, Brian M Sadler, Daniel S Stein
Epilepsy Research|March 12, 2004
Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapyBarry E Gidal, Raj Sheth, Jennifer Parnell, et al.
Clinical and Translational Science|February 25, 2022
Population pharmacokinetic modeling and simulations of berotralstat for prophylactic treatment of attacks of hereditary angioedemaAmanda Mathis, Mark Sale, Melanie Cornpropst, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 22, 2019
Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance?Ayyappa Chaturvedula, Stacie Calad-Thomson, Chao Liu, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 16, 2026
Multi-objective optimization in population pharmacokinetic model selection and optimization: application of NSGA-II in pyDarwinXinnong Li, Mark Sale, James Craig, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 29, 2021
Population pharmacokinetics and exposure-response modeling for evinacumab in homozygous familial hypercholesterolemiaXia Pu, Mark Sale, Feng Yang, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 4, 2021
Development of a genetic algorithm and NONMEM workbench for automating and improving population pharmacokinetic/pharmacodynamic model selectionMohamed Ismail, Mark Sale, Yifan Yu, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 17, 2022
Population Pharmacokinetic Modeling of Lucitanib in Patients with Advanced CancerMingxiang Liao, Jie Zhou, Kenton Wride, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
British Journal of Clinical Pharmacology|June 19, 2013
A genetic algorithm based global search strategy for population pharmacokinetic/pharmacodynamic model selectionMark Sale, Eric A Sherer
Clinical and Translational Science|February 6, 2025
AI In Action: Redefining Drug Discovery and DevelopmentAnshul Kanakia, Mark Sale, Liang Zhao, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2002
Pharmacokinetic modeling and simulations of interaction of amprenavir and ritonavirMark Sale, Brian M Sadler, Daniel S Stein
Epilepsy Research|March 12, 2004
Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapyBarry E Gidal, Raj Sheth, Jennifer Parnell, et al.
Clinical and Translational Science|February 25, 2022
Population pharmacokinetic modeling and simulations of berotralstat for prophylactic treatment of attacks of hereditary angioedemaAmanda Mathis, Mark Sale, Melanie Cornpropst, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 22, 2019
Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance?Ayyappa Chaturvedula, Stacie Calad-Thomson, Chao Liu, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 16, 2026
Multi-objective optimization in population pharmacokinetic model selection and optimization: application of NSGA-II in pyDarwinXinnong Li, Mark Sale, James Craig, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 29, 2021
Population pharmacokinetics and exposure-response modeling for evinacumab in homozygous familial hypercholesterolemiaXia Pu, Mark Sale, Feng Yang, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 4, 2021
Development of a genetic algorithm and NONMEM workbench for automating and improving population pharmacokinetic/pharmacodynamic model selectionMohamed Ismail, Mark Sale, Yifan Yu, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 17, 2022
Population Pharmacokinetic Modeling of Lucitanib in Patients with Advanced CancerMingxiang Liao, Jie Zhou, Kenton Wride, et al.
Pageof 3